Sarcopenia as a Predictor of Survival Among Patients With Organ Metastatic Cervical Cancer.

CONCLUSIONS: High PMI was determined to be a favorable prognostic factor for patients with organ metastatic cervical cancer. Moreover, patients with organ metastatic cervical cancer who have a PMI > 3.72 cm2 /m2 may benefit from CCRT as an initial treatment. PMID: 32253779 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32253779?dopt=Abstract

Source: Nutrition in Clinical Practice - April 5, 2020 Category: Nutrition Authors: Yoshikawa N, Shirakawa A, Yoshida K, Tamauchi S, Suzuki S, Kikkawa F, Kajiyama H Tags: Nutr Clin Pract Source Type: research